-
Calcitriol Treatment Attenuates Dopaminergic Neurodegeneration in Mice Model of Parkinson’s Disease
-
Camptocormia in patients with multiple system atrophy with different disease durations
-
Can a “Shopping bag Tremor” be a Pre-diagnostic sign of Parkinson’s Disease?
-
Can bedside neurophysiological testing aid the differential diagnosis of bilateral upper limb action tremors in young-onset patients?
-
Can clinical outputs predict BDNF levels in people with Parkinson’s disease?
-
Can Handwriting Movement Abnormalities Serve as an Early Biomarker of Transition to Manifest Huntington’s disease?
-
Can post-operative local field potentials in the STN predict long-term DBS efficacy in Parkinson’s disease?
-
Can we customize tune for asymmetric tremor with differentiated Deep brain stimulation frequencies?
-
Can we stage tau pathology in PSP?
-
Cancerous inhibitor of protein phosphatase 2A in Parkinson’s disease
-
Candidate plasma miRNAs and EV protein as novel biomarkers in Parkinson’s disease patients with cognitive impairment and dementia
-
Canine Aromatic Detection of Parkinson’s Disease: Can Dogs Identify Prodromal Parkinsonism?
-
CAPN1 mutations are more common than expected in patients with hereditary spastic paraparesis
-
Cardiac Autonomic Dysfunction in Patients with Multiple System Atrophy: A cross-sectional study
-
Cardiac Dysautonomia in Parkinson’s Disease
-
Cardiac Safety of PBT434, an Inhibitor of Alpha-Synuclein Aggregation for the Treatment of Multiple System Atrophy (MSA)
-
Cardiovascular Fitness, Plasma Biomarkers and Dopaminergic Denervation in Parkinson’s Disease
-
Cardiovascular risk factors in a pre-manifest and manifest population of Huntington’s disease
-
Care-giver Burden in Parkinson’s Disease and Atypical Parkinsonism in Indian Patients Using Zarit Burden Interview scale
-
Carers of People Living with Parkinson’s Disease, the 2019 European Realities
-
Case of percussionist dystonia in playing the janggu, a traditional Korean percussive instrument
-
Case Report: Pseudoatetosis as Manifestation of the Vitamin B12 Deficit
-
Case series of unilateral subthalamotomy through implanted deep electrodes: rescue therapy in Parkinson’s disease patients submitted to deep brain stimulation surgery
-
Caspr2 antibody associated spinal myoclonus
-
Catatonia, Parkinsonism and Dystonia in a patient with Osmotic Demyelination Syndrome
-
CBIT Response in Clinical Practice: The Potential Importance of Comorbidities and Tic location
-
Ceftriaxone improves motor function in a rat hemi-parkinsonian model: Potential to delay bilateral progression of motor deficits in Parkinson’s disease
-
Cerebellar deep brain stimulation for secondary dystonia: A Case Report
-
Cerebellar structural covariance networks in young people with Tourette syndrome
-
Cerebral microvascular injury provoked by alpha-synuclein preformed fibrils exacerbates cognitive dysfunction in Parkinson’s disease
-
Cerebrospinal fluid protein markers of cognition in early Parkinson’s disease
-
Cerebrotendinous Xanthomatosis Tremor Successfully Controlled post-VIM-Deep Brain Stimulation
-
Challenge Point Guide: Characterizing exercises performed in multilevel Parkinson-specific community exercise classes
-
Changes in fecal microbiota composition in patients with Huntington’s disease in China
-
Changes in the AKT/GSK3 pathway in the cerebellum increase susceptibility to movement disorders in a rat model of post-traumatic stress disorder
-
Changes of gait parameters in Parkinson disease (PD) patients who underwent Deep Brain Stimulation (DBS) Surgery: A prospective one year study
-
Characterising Oromandibular Dystonia in Multiple System Atrophy: A video analysis
-
Characteristics of prescribers for Parkinson’s disease patients: A nationwide study on 2017 Medicare data
-
Characterization of ataxia in Sjogren’s syndrome
-
Characterization of Lewy bodies-induced neurodegeneration and synucleopathy in wild-type mice
-
Characterization of novel alpha-synuclein aggregation model of Parkinson’s disease
-
Characterization of pallidal neuronal activity in X-linked dystonia-parkinsonism – a model disease for compartment degeneration in the striatum
-
Characterization of striatal dopaminergic neurotransmission in the rat pre-formed fibril models of Parkinson’s disease
-
Characterization of the pattern of daily motor fluctuations in Parkinson’s disease patients based on home diaries
-
Characterization of the swallow function in Parkinson patients with or without STN DBS
-
Characterizing Global Cohorts with Monogenic Parkinson’s Disease
-
Characterizing the genetic architecture of Parkinson’s disease in Latinos
-
CHCHD2 mRNA levels in erythrocyte are reduced in patients with multiple system atrophy
-
CHIEF-PD: Cholinesterase Inhibitor to prEvent Falls in Parkinson’s Disease
-
Children with Tourette syndrome show greater variability in an arm-position-matching proprioceptive task
-
China’s Jidong Restless Legs Syndrome Cohort Study: Objectives, Design, and Baseline Screening
-
Cholinergic basal forebrain atrophy and cognitive decline in advanced Parkinson’s disease
-
Chorea: A Case Series
-
Choreoathetosis post lentiform nucleus ischemic Stroke: A unique pathology and presentation
-
Chromogranin B in cerebrospinal fluid as a novel biomarker for Progressive supranuclear palsy
-
Chronic form of Pisa syndrome after prolonged exposure to low-dose amisulpride treatment
-
Chronic wireless streaming of pallidal and cortical recordings in Parkinson’s disease over 1000 hours at home
-
Circadian rhythm alterations in an in vitro cellular model of Spinocerebellar ataxia type 17
-
Claims Data Analysis of Parkinson’s Disease Medication Utilization
-
Clinical and demographic characteristics of patients with Functional Movement Disorders in Spain: a Consecutive Cohort Study
-
Clinical and etiological aspects of movement disorders in a low-income country: Case of Mali
-
Clinical and genetic abnormalities in patients with Friedreich’s ataxia: A genotype-phenotype correlation
-
Clinical and Genetic Characteristics of the University of Pennsylvania Parkinson’s Disease Population: Results from the Molecular Integration in Neurological Diagnosis (MIND) Initiative
-
Clinical and genetic profile of Familial Parkinson´s disease in Cali – Colombia
-
Clinical and imagiological features in Portuguese patients with SPG7 mutations
-
Clinical and kinematic assessment of a glove-based tremor dampener in patients with essential tremor
-
Clinical and neurological features of the course of parkinsonism in the presence of chronic renal disease
-
Clinical and nuclear neuroimaging features of Parkinson’s disease with dysphagia
-
Clinical and oculomotor correlates with freezing of gait in Chinese Parkinson’s disease
-
Clinical and self-reported falls prediction tools in people with Parkinson’s disease
-
Clinical characteristics of pain in Parkinson’s disease dementia
-
Clinical characterization and disease progression in spinocerebellar ataxia type 35: A case series
-
Clinical correlation with the Genotype of Friedreich’s Ataxia (FRDA) patients in Indian population
-
Clinical Dementia Rating Scale Sum of Boxes (CDR-SOB) in Parkinson’s Disease: Longitudinal Results
-
Clinical Effect of Impedance Variations within Normal Limits in Parkinson’s Disease Treated with Subthalamic Deep Brain Stimulation
-
Clinical factors associated with neuronal loss in the substantia nigra
-
Clinical features and natural course of corticobasal degeneration and progressive supranuclear palsy presenting as corticobasal syndrome
-
Clinical Features of Depressive Disorders in Parkinson’s Disease: Possibilities of their Correction
-
Clinical features of impaired communication in patients with multiple system atrophy
-
Clinical Implication of Stimulus Induced Dyskinesia in Pallidal Deep Brain Stimulation for Advanced Parkinson’s Disease
-
Clinical outcome of 6-pyruvoyl-tetrahydropterin synthase deficiency (PTPSd)
-
Clinical outcomes after DBS surgery in cognitively impaired patients with PD
-
Clinical profile and cerebral metabolic characteristic of cognitive impairments in multiple system atrophy
-
Clinical progression of Parkinson’s disease: insights from the NINDS common data elements
-
Clinical research of serum uric acid levels in Parkinson’s disease
-
Clinician Ratings of Cognition Predict Trajectory of Cognitive Decline in Newly Diagnosed Individuals with Parkinson’s disease
-
Clock Drawing Test does not Differentiate Alzheimer’s Disease from Parkinson’s Disease Dementia
-
Clustering physical interventions for patients with Parkinson’s disease in network meta-analyses
-
Cognitive and functional predictors of ADL performance in persons with Parkinson’s Disease
-
Cognitive and psychiatric symptoms are associated with walking difficulties in mild Parkinson’s disease
-
Cognitive Differences Between Men and Women with Progressive Supranuclear Palsy
-
Cognitive Fatigue from Attention Cognitive Load in Parkinson’s Disease
-
Cognitive function and depressive symptoms among older adults with serious difficulty walking in Americans
-
Cognitive function and quality of life in Parkinson’s disease: A cross-sectional study
-
Cognitive impairment related networks of functional MRI in Parkinson’s disease
-
Cognitive pretesting of the Functional Rating Scale 2.0 for Huntington’s disease (FuRST 2.0): An iterative process
-
Cognitive profile of the COPPADIS cohort: Sociodemographic characteristics, lifestyle, neuropsychiatric and non-motor(NM) associated features and potentially treatable variables
-
Cognitive profiling of patients with neurodegenerative disorders
-
Combined therapy VS only levodopa therapy in a 5-years follow up cohort
-
Comparative analysis of cognitive function between unilaterally and bilaterally affected Parkinson’s disease
-
Comparative analysis of the quality of life between healthy elderly people and those with Parkinson’s disease
-
Comparative diagnostic accuracy of ACE-III and MoCA for detecting mild cognitive impairment patients with Parkinson’s disease
-
Comparative evaluation of the biomechanical analysis of gait in patients with Parkinson’s disease vs controls of the Zambrano Hellion Hospital
-
Compare the eficacy of cleaning the vallecular space by the chin down posture versus a novel maneuver
-
Compared the effects of probiotics and Anti-PD particles on the behavior of Parkinson’s disease mice model
-
Comparing the effects of rosemary and selegiline on behavioral symptoms of Parkinson’s animal model in mice
-
Comparison between the results of two multidisciplinary health education program to improve the level of knowledge on key points for the management of motor and non-motor symptoms in people with Parkinson’s disease: a randomized clinical trial
-
Comparison of 123I-MIBG myocardial scintigraphy and 123I-FP-CIT SPECT between dementia with Lewy bodies and Parkinson’s disease
-
Comparison of accelerometers used for measurement of upper body postural tremor, and gait and balance
-
Comparison of Categorical- and Verbatim-Reported Postural Instability Symptoms Among Fox Insight Parkinson Research Participants
-
Comparison of Dystonia Rating Scales in Children with Primary (Isolated) Dystonia
-
Comparison of gait measures in a clinic and a community setting in people with and without Parkinson’s disease
-
Comparison of gait pattern characteristics during Parkinson’s disease progression – Analysis of gait during the dual-task walking
-
Comparison of omnidirectional versus unidirectional STN-DBS – Impact on gait and balance in Parkinson’s disease
-
Comparison of Safety and Tolerability of Deutetrabenazine (DTBZ) During Titration and Maintenance in Patients With Tardive Dyskinesia (TD)
-
Comparison of the effect of hydroalcoholic extract of olive leaf and levodopa on reducing parkinson’s symptoms in animal model
-
Comparisons of motor and non-motor features between essential tremor with and without head tremor patiens
-
Compartment-specific blockade of dopamine uptake in nigrostriatal pathway reveals role for nigral dopamine function in movement frequency in open-field
-
Complex differential diagnosis in a young-onset dementia case, leading to behavioral-variant frontotemporal dementia
-
Complex patterns of dyskinesias in patients chronically treated with enterally administered levodopa/carbidopa gel
-
Complicated hereditary spastic paraplegia like presentation of homozygous c.2222G>A mutation in PLA2G6
-
Comprehensive Screening of Genetic, Genomic, Mitochondrial, and Microbiome Associations with Phenotypic Measures in the Dominican Republic PKAN Cohort
-
Concerns in patients with Parkinson’s disease in China: A content analysis of data from social listening
-
Concordance of different evaluation approaches of non-motor symptoms in patients with cervical dystonia
-
Concurrent SCA3 and SCA10 in a young man with ataxia and prominent dystonia
-
Confrontation Naming Deficit in Lewy Body Dementia Patients with Alzheimer’s Disease Co-Pathology
-
Connecting digital mobility outcomes with clinical assessments in disorders such as Parkinson’s disease: the Mobilise-D study
-
Contribution of coding/noncoding variants in NUS1 to late-onset sporadic Parkinson’s disease
-
Convolutional neural network for discriminating between Multiple System Atrophy and Healthy Control, comparing MRI modalities and highlighting the disease signature
-
Cooper-deficiency myeloneuropathy in Wilson´s Disease as a result of D-penicillamine treatment: A case report
-
Copper induced neurobehavioral features of Parkinson’s disease and oxidative stress and their abatement by Eugenol
-
Correlation and comparison of the lipid profile and the body fat mass in people with Parkinson’s disease submitted to three physical therapies
-
Correlation Between Dyskinesia and Quality of Life at Baseline and After 12 months of Treatment with LCIG in Patients with Advanced Parkinson’s Disease
-
Correlation between location of active contacts and weight gain after subthalamic nucleus deep brain stimulation in Parkinson’s disease
-
Correlation of brain activity measured using quantitative electroencephalography and cognitive function in patients with de novo Parkinson’s disease
-
Correlation of Lead Location with Clinical Outcomes in a Double-Blinded Randomized Controlled Trial Evaluating Subthalamic Deep Brain Stimulation in Parkinson’s Disease (INTREPID)
-
Correlations between amantadine usage, gait, and cognition in PSP: a post hoc analysis of the davunetide trial
-
Cortical Activation during Dynamic Sway of young Fragile X Premutation Carriers
-
Cortical network fingerprint and prediction of deep brain stimulation-induced speech impairment in essential tremor
-
Cortical pathology in Glucocerebrosidase mutation carriers with anxiety: An MRI study
-
Cortical thickness and volume to automatically identify Parkinson’s patients using SVM
-
Cost-Analysis of the Use of IncobotulinumtoxinA and AbobotulinumtoxinA for the Treatment of Post-Stroke Upper Limb Spasticity Based on Recommended Dosing for Muscles and Clinical Patterns
-
Cost-Utility Analysis of Flexible Intervals with IncobotulinumtoxinA Versus Fixed Dosing with OnabotulinumtoxinA in the Management of Cervical Dystonia and Blepharospasm in Major Canadian Markets
-
Cranial functional movement disorders: Clinical features, associated conditions and precipitating factors
-
Creating moments that matter – A person-centered approach for the geriatric patient at the Parkinson Unit at Vrinnevi Hospital, Norrköping, Sweden
-
Creating National Competencies in Physical Activity for Exercise Professionals Working with People with Parkinson’s Disease
-
Cross-linguistic exploration of speech treatment for Parkinson’s disease: is a universal speech treatment approach plausible?
-
CSF inflammatory cytokines and correlation with clinical features in early, untreated PD patients
-
Cultural disparities in deep brain stimulation (DBS) decision making in patients with Parkinson’s disease (PD): Updates
-
Customizing Rehabilitation based on oromotor function assessed with dynamic MRI in early Parkinson’s disease
-
CVT-301 treatment provides consistent and clinically significant improvements in Unified Parkinson’s Disease Rating Scale Part III (UPDRS-III) over 12 weeks
-
Cytokines and Brain Specific Antibodies in Experimental Cellular and Molecular Treatment of Huntington’s Diseases
MDS Virtual Congress 2020
September 12-16, 2020. Virtual Congress. www.mdscongress.org